| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Apr―17 |
SARS-CoV-2 remodels the landscape of small non-coding RNAs with infection time and symptom severity |
Julia Corell-Sierra, Joan Marquez-Molins, María-Carmen Marqués, Andrea Gabriela Hernandez-Azurdia, Roser Montagud-Martínez, María Cebriá-Mendoza, et al. (+5) José M. Cuevas, Eliseo Albert, David Navarro, Guillermo Rodrigo, Gustavo Gómez |
| 2 |
[GO] |
2024―Apr―05 |
Metacell-based differential expression analysis identifies cell type specific temporal gene response programs in COVID-19 patient PBMCs |
Kevin O’Leary, Deyou Zheng |
| 3 |
[GO] |
2023―Apr―14 |
A quantitative systems pharmacology model of the pathophysiology and treatment of COVID-19 predicts optimal timing of pharmacological interventions |
Rohit Rao, Cynthia J. Musante, Richard Allen |
| 4 |
[GO] |
2022―Oct―10 |
Old drugs, new tricks: leveraging known compounds to disrupt coronavirus-induced cytokine storm |
Spencer Richman, Cole Lyman, Anastasia Nesterova, Anton Yuryev, Matthew Morris, Hongbao Cao, et al. (+3) Chris Cheadle, Gary Skuse, Gordon Broderick |
| 5 |
[GO] |
2021―May―24 |
Comparative transcriptome analysis reveals key epigenetic targets in SARS-CoV-2 infection |
Marisol Salgado-Albarrán, Erick I. Navarro-Delgado, Aylin Del Moral-Morales, Nicolas Alcaraz, Jan Baumbach, Rodrigo González-Barrios, Ernesto Soto-Reyes |
|
